Professor Saye Khoo

Professor Saye Khoo is Professor in the Department of Pharmacology at the University of Liverpool, and Honorary Consultant Physician in Infectious Diseases at the Royal Liverpool University Hospital. His current research includes clinical trials of antimicrobials, characterisation of drug-drug interactions involving antiviral agents, and pharmacology of anti-infective agents.

Prof. Khoo leads the UK Early-Phase COVID-19 Antiviral Trials Platform (AGILE) for experimental antivirals, and is Chief Investigator of the international DolPHIN consortium undertaking RCTs to establish safety and efficacy of HIV antivirals in pregnant women and their infants. He also leads the Liverpool Drug Interactions programme which has developed prescribing tools for managing drug interactions in HIV, hepatitis, and COVID-19 treatments. Collectively the tools returned over 16 million searches in 2023, and have been translated into Spanish, Portuguese and Japanese. Khoo has established the Liverpool Bioanalytical Facility, which undertakes GCP measurement of drug concentrations in plasma, cells, and tissue compartments.